Christopher John Sayed, MD, FAAD
SESSIONS
F058 Advanced Management Strategies for Hidradenitis Suppurativa
Mar 9, 2024
•
1:00 PM - 3:00 PM
•
Room 20A
DISCLOSURES
AbbVie – Advisory Board(Fees), Investigator(Fees), Speaker(Fees); Alumis – Consultant(Fees); AstraZeneca – Consultant (1099 relationship)(Fees); ChemoCentryx – Investigator(Grants/Research Funding); Eli Lilly – Stockholder Public Company(Stock); Incyte – Consultant (1099 relationship)(Fees); Incyte Corporation – Investigator(Grants/Research Funding); InflaRx – Consultant(Fees), Investigator(Grants/Research Funding); Novartis – Investigator(Fees), Speaker(Honoraria); Sanofi – Consultant (1099 relationship)(Fees); UCB – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding);